-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Prevention and Monitoring

PhD Trainee
Program: Scientific Workshops @ ASH
Wednesday, December 2, 2020: 8:35 AM-9:35 AM
Moderator:
Disclosures:
No relevant conflicts of interest to declare.
Prevention and Treatment of Adverse Hemostatic Outcomes in Infectious Disease

Jean M. Connors, MD

Brigham & Women's Hospital, Dana Farber Cancer Institute, Boston, MA
The Role of the Coagulation Laboratory in Treating the Infectious Disease Patient

Jerrold H Levy, MD

Departments of Anesthesiology, Critical Care, and Surgery (Cardiothoracic), Duke University Medical Center, Durham, NC
Monitoring for Adverse Hemostatic Outcomes at the Population Level

Cheryl Maier, MD, PhD

Emory University School of Medicine, Atlanta, GA
Prevention and Monitoring Panel Discussion and Live Q&A
See more of: Scientific Workshops @ ASH
<< Previous Session | Next Session >>